• Monomethyl Auristatin E: Precision Payloads for ADC Workflow

  2026-06-24

  Monomethyl auristatin E (MMAE) is redefining targeted cancer therapy as a high-potency antimitotic payload in antibody-drug conjugate (ADC) development. Explore stepwise workflow strategies, troubleshooting, and translational insights that maximize MMAE's performance across in vitro and in vivo oncology models.

• Bazedoxifene: Selective Estrogen Receptor Modulator in Resea

  2026-06-23

  Bazedoxifene delivers unrivaled control for estrogen receptor signaling studies, enabling precise modeling of osteoporosis and tissue-selective pharmacology. This article details experimental workflows, troubleshooting insights, and key innovations to maximize reproducibility in preclinical research.

• Salinomycin: Polyether Ionophore Antibiotic for HCC Research

  2026-06-23

  Salinomycin stands out as a powerful polyether ionophore antibiotic in hepatocellular carcinoma (HCC) research, uniquely targeting Wnt/β-catenin signaling and drug resistance pathways. This guide delivers actionable protocols, troubleshooting insights, and comparative analysis to unlock Salinomycin's full experimental potential.

• Exercise-Induced Muscle Vesicles Enhance Amyloid Clearance i

  2026-06-22

  This study uncovers a novel mechanism by which swimming exercise alleviates cognitive dysfunction in Alzheimer's disease (AD) mice. The findings reveal that skeletal muscle-derived extracellular vesicles (SKM-EVs), enriched after exercise, are taken up by microglia and promote amyloid plaque clearance, suggesting new therapeutic directions for AD.

• Recognizing Stroke Mimics: Lessons from Prochlorperazine-Ind

  2026-06-22

  The reference study presents a rare case of prochlorperazine-induced hemidystonia that closely mimicked acute ischemic stroke in a pregnant patient, highlighting the diagnostic challenges in emergency settings. This case emphasizes the need for systematic exclusion of stroke mimics before administering fibrinolytic therapy and provides practical insight into protocol optimization for neurologic emergencies.

• pH-Responsive i-Motif ASO Prodrugs for Targeted MYCN Silenci

  2026-06-21

  This study introduces a series of pH-responsive hairpin antisense oligonucleotide (ASO) prodrugs leveraging the i-motif structure to enable controlled release and enhanced silencing of MYCN in tumor cells. The research demonstrates how structural tuning of ASO hairpins modulates stability and release, offering a rational design strategy for tumor-microenvironment-responsive gene therapies.

• Risedronate Sodium: FPPS Inhibitor Workflows for Bone Resear

  2026-06-20

  Risedronate Sodium, a potent FPPS inhibitor, offers researchers a robust toolkit for dissecting bone metabolism and antiproliferative effects in tumor models. This guide details advanced protocols, delivery innovations, and troubleshooting strategies that maximize its impact across osteoporosis, cancer research, and pulmonary applications.

• Modified IVT-mRNA Encoding TPO Stimulates Thrombopoiesis in

  2026-06-19

  This study demonstrates that chemically modified in vitro-transcribed (IVT) mRNA encoding thrombopoietin (TPO) can robustly stimulate platelet production in mice, offering a promising approach to treat thrombocytopenia. The research highlights improved safety and efficacy over conventional protein or receptor agonist therapies, with implications for the future of mRNA-based therapeutics.

• Reliable Gene Editing with EZ Cap™ Cre mRNA (m1Ψ): Lab Scena

  2026-06-19

  This article delivers a scenario-driven examination of common laboratory challenges in Cre-lox gene editing, focusing on how EZ Cap™ Cre mRNA (m1Ψ) (SKU R1030) from APExBIO addresses workflow reproducibility, translation efficiency, and low immunogenicity. Researchers will find actionable guidance and validated parameters for optimizing cell-based assays using advanced mRNA technology.

• PXR Activation Enhances Urine Concentration via AVP Upregula

  2026-06-18

  This study demonstrates that activation of the pregnane X receptor (PXR) in the hypothalamus increases urine concentration by upregulating arginine vasopressin (AVP) expression. These findings reveal a novel neuroendocrine function for PXR, with potential implications for water homeostasis disorders.

• Applied Workflows with Verteporfin: Precision in CL 318952 A

  2026-06-18

  Verteporfin, supplied by APExBIO, is transforming photodynamic therapy and autophagy research with its dual-action profile. This guide demystifies practical protocols, highlights troubleshooting strategies, and bridges recent mechanobiology insights for next-generation cell viability and apoptosis assays.

• MLN4924 HCl Salt in Host-Pathogen Dynamics: Beyond Cancer Re

  2026-06-17

  Explore how MLN4924 HCl salt, a NEDD8-activating enzyme inhibitor, advances research on protein turnover in viral immunity and inflammation. This article uniquely bridges cancer biology and host-pathogen interaction studies.

• Phosphatase Inhibitor Cocktail 1: Precision in Phosphoproteo

  2026-06-17

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) empowers researchers to preserve phosphorylation states with exceptional fidelity, even in challenging workflows like signaling pathway dissection and viral infection models. This guide details advanced use-cases, troubleshooting, and cutting-edge protocol enhancements, providing an actionable resource for maximizing reproducibility in phosphoproteomics.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: Advanc

  2026-06-16

  This study presents a non-viral, intravesical delivery of p21 mRNA-loaded lipid nanoparticles as a tumor suppressor replacement strategy for bladder cancer. The approach demonstrates robust antitumor efficacy with minimal systemic exposure, suggesting a promising direction for localized mRNA therapies in non-hepatic solid tumors.

• RSAD2 Drives Placental Lipid Accumulation in SLE Pregnancies

  2026-06-16

  Ding et al. identify RSAD2 as a pathogenic interferon-stimulated gene at the maternal-fetal interface in systemic lupus erythematosus (SLE) pregnancies. Their work demonstrates that RSAD2 excess impairs placental vasculogenesis through lipid accumulation, and that targeted inhibition of RSAD2 can alleviate vascular inflammation, highlighting a novel pathway for intervention in SLE-associated pregnancy complications.

10321 records 1/689 page Next 12345 下5页 Last page